GLP-1 & Metabolic Peptides: Research Overview of Semaglutide, Tirzepatide & More
A research overview of GLP-1 and dual/triple receptor agonist peptides including Semaglutide, Tirzepatide, Retatrutide, and Cagrilintide for laboratory study.
Read →
GLP / Metabolic Peptides
Research overviews of GLP-1 receptor agonists and metabolic signaling peptides including Semaglutide, Tirzepatide, Retatrutide, and Cagrilintide. All content is for laboratory research purposes only.
Cagrilintide: Combination Research Notes
Combination studies require careful attribution of effects to each agent. Protocol details often explain differences between results.
Read →
Tirzepatide: Interpreting Trial Readouts
Different studies may use different dosing schedules and populations. Compare outcomes with consistent metrics where possible.
Read →
Cagrilintide Research Guide (Amylin Analog)
Amylin analog research often looks at satiety signaling and combination pathways. Combination-study results depend heavily on protocol and population.
Read →
Metabolic Signaling 101 for GLP Pathways
GLP pathways are often studied via receptor binding and downstream signaling. Assay choice (in vitro/in vivo) drives what conclusions are valid.
Read →
Tirzepatide Research Guide: Dual GLP-1/GIP Receptor Agonism Explained
Tirzepatide research guide: dual GLP-1/GIP receptor agonism, adipose tissue biology, hepatic metabolism, and comparison with Semaglutide for laboratory researchers.
Read →